| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Corp Dev & Strategy | Restricted stock units | 24,300 | $863,622 | $35.54 | 05 Mar 2025 | Direct |
| AGIOS PHARMACEUTICALS, INC. | Chief Corp Dev & Strategy | Stock options (right to buy) | 55,374 | 05 Mar 2025 | Direct | ||
| CARGO Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 19 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRGX | CARGO Therapeutics, Inc. | 19 Aug 2025 | 2 | $0 | 4 | Director | 19 Aug 2025, 16:44 |
| CRGX | CARGO Therapeutics, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 19:33 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 05 Mar 2025 | 2 | $0 | 4 | Chief Corp Dev & Strategy | 07 Mar 2025, 16:18 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 05 Mar 2025 | 0 | $0 | 3 | Chief Corp Dev & Strategy | 07 Mar 2025, 16:15 |
| CRGX | CARGO Therapeutics, Inc. | 04 Jun 2024 | 1 | $0 | 4 | Director | 06 Jun 2024, 16:30 |
| CRGX | CARGO Therapeutics, Inc. | 09 Nov 2023 | 1 | $0 | 4 | Director | 13 Nov 2023, 18:46 |
| CRGX | CARGO Therapeutics, Inc. | 09 Nov 2023 | 0 | $0 | 3 | Director | 09 Nov 2023, 17:09 |